Seganserin is an orally active 5-HT receptor antagonist with a plasma half-life of 26.1 ± 12.9 (S.D.) h. Seganserin can be utilized in neurological research[1].
References
[1] Dijk DJ, et al. Effects of seganserin, a 5-HT2 antagonist, and temazepam on human sleep stages and EEG power spectra. Eur J Pharmacol. 1989 Nov 21;171(2-3):207-18. DOI:10.1016/0014-2999(89)90109-x
